Close Menu

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Agilent Technologies today announced BGI has become a certified service provider for Agilent's SureSelect XT Target Enrichment System for next-generation sequencing.

Based in Shenzhen, China, BGI becomes the first SureSelect XT CSF in that country, and is certified for all SureSelect XT target enrichment protocols, including human all-exon, SureSelect indexing, DNA capture, RNA capture, kinome RNA, and custom kits.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Google's Project Nightingale has collected health information on millions of Americans, according to the Wall Street Journal.

An opinion piece at The Hill criticizes the proposed plan to collect DNA samples from migrants at the US border.

Nature News writes that women in chemistry are less likely to have their manuscripts accepted for publication.

In PNAS this week: tRNA fragment signature for chronic lymphocytic leukemia, genomic sites sensitive to ultraviolet radiation in melanocytes, and more.

Dec
04
Sponsored by
BC Platforms

This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).